Peptide Comparison
ProstamaxvsTestagen
Prostate-specific tetrapeptide bioregulator (Lys-Glu-Asp-Pro) that normalizes prostatic epithelial differentiation through chromatin remodeling at prostate gene promoters, restores the proliferation-apoptosis balance disrupted in benign prostatic hyperplasia, and reduces inflammatory cytokine signaling in aging prostate tissue
Testicular tetrapeptide bioregulator (Lys-Glu-Asp-Gly) that normalizes HPG axis signaling through DNA minor groove binding at testicular gene promoters, increases testosterone synthesis by restoring Leydig cell function, and modulates neuroendocrine feedback loops controlling gonadotropin secretion in aging males
At a Glance
Quick
comparison
Dose Range
Prostamax
5–10 mg
Testagen
5–10 mg
Frequency
Prostamax
Once daily
Testagen
Once daily
Administration
Prostamax
Sublingual (enteric-coated capsules)
Testagen
Sublingual (enteric-coated capsules)
Cycle Length
Prostamax
12+ weeks
Testagen
12+ weeks
Onset Speed
Prostamax
Gradual (3-4 weeks)
Testagen
Gradual (3-4 weeks)
Evidence Level
Prostamax
Limited human trials
Testagen
Limited human trials
Efficacy
Benefit
ratings
Prostate Health
Urinary Function
Tissue Inflammation
Testosterone Support
Male Aging Health
Reproductive Function
Technical Data
Compound
specifications
Prostamax
Molecular Formula
C20H33N5O9
Molecular Weight
487.5 g/mol
Half-Life
Short plasma half-life typical of tetrapeptides (minutes to hours); biological effects persist for weeks to months through chromatin remodeling at prostate gene promoters; metabolized to constituent amino acids
Bioavailability
Absorbed via intestinal peptide transporters (PepT1) in oral formulation; rapid absorption from subcutaneous injection sites; efficient cellular uptake due to short tetrapeptide structure with proline conferring conformational stability
CAS Number
Not publicly registered
Testagen
Molecular Formula
C17H29N5O9
Molecular Weight
447.4 g/mol
Half-Life
Short plasma half-life typical of tetrapeptides (minutes to hours); biological effects persist for weeks to months through epigenetic modifications to testicular gene expression; metabolized to constituent amino acids
Bioavailability
Absorbed via intestinal peptide transporters (PepT1) in oral formulation; rapid absorption from subcutaneous injection sites; efficient cellular uptake and nuclear penetration due to short tetrapeptide structure
CAS Number
Not publicly registered
Protocols
Dosing
tiers
Prostamax
Testagen
Applications
Best
suited for
Prostamax
Age-related benign prostatic hyperplasia (BPH) requiring tissue-level normalization
Prostamax is particularly well-suited for individuals focused on age-related benign prostatic hyperplasia (bph) requiring tissue-level normalization. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Prostate geroprotection — preserving prostatic epithelial function during aging
Prostamax is particularly well-suited for individuals focused on prostate geroprotection — preserving prostatic epithelial function during aging. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Chronic prostatitis support through anti-inflammatory tissue-level mechanisms
Prostamax is particularly well-suited for individuals focused on chronic prostatitis support through anti-inflammatory tissue-level mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Comprehensive Khavinson bioregulator protocols targeting male genitourinary health
Prostamax is particularly well-suited for individuals focused on comprehensive khavinson bioregulator protocols targeting male genitourinary health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Testagen
Age-related testosterone decline (andropause) requiring physiological restoration rather than replacement
Testagen is particularly well-suited for individuals focused on age-related testosterone decline (andropause) requiring physiological restoration rather than replacement. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
HPG axis normalization in aging males with suboptimal hormonal signaling
Testagen is particularly well-suited for individuals focused on hpg axis normalization in aging males with suboptimal hormonal signaling. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Comprehensive Khavinson bioregulator protocols targeting male reproductive health
Testagen is particularly well-suited for individuals focused on comprehensive khavinson bioregulator protocols targeting male reproductive health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Testicular geroprotection — preserving Leydig and Sertoli cell function during aging
Testagen is particularly well-suited for individuals focused on testicular geroprotection — preserving leydig and sertoli cell function during aging. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety Profile
Side
effects
Prostamax
Common
- Injection site reaction
- Mild fatigue
- Urinary frequency changes
- Mild headache
Uncommon
- Mild pelvic discomfort
Serious
- No documented serious adverse effects
Testagen
Common
- Injection site reaction
- Mild fatigue
- Mild headache
- Libido fluctuation
Uncommon
- Mild acne or skin oiliness
Serious
- No documented serious adverse effects
Research Status
Safety
& evidence
Prostamax
Evidence Level
Limited human trials
FDA Status
Research compound
Safety Overview
Prostamax (proprietary peptide blend) demonstrates limited published safety data; primarily used in clinical practice based on observational evidence. No serious adverse events reported in clinical use; mild gastrointestinal tolerance issues occasionally reported. Derived from bovine prostatic tissue; potential allergenicity in beef-sensitive individuals requires screening. Quality control and standardization vary across manufacturers.
Contraindications
- xKnown or suspected prostate cancer — potential modulation of prostatic gene expression requires oncological clearance
- xKnown hypersensitivity to peptide bioregulators or constituent amino acids (lysine, glutamic acid, aspartic acid, proline)
- xSevere urinary retention requiring surgical intervention — epigenetic therapy cannot address acute obstruction
- xConcurrent anti-androgen therapy without medical supervision — potential interaction with hormonal mechanisms
Testagen
Evidence Level
Limited human trials
FDA Status
Research compound
Safety Overview
Testagen (lyophilized peptide complex) lacks published human safety data—all information derives from unpublished manufacturer data and theoretical extrapolation from rat studies. As an androgen secretagogue, it carries class risks including erythrocytosis (elevated red blood cell count), liver enzyme elevation, lipid profile unfavorable changes (reduced HDL, increased LDL), and prostate-related effects including urinary obstruction and potential malignancy acceleration. Cardiovascular risk including hypertension and increased thrombotic events are theoretical concerns based on androgen class pharmacology.
Contraindications
- xKnown hypersensitivity to peptide bioregulators or constituent amino acids (lysine, glutamic acid, aspartic acid, glycine)
- xHormone-sensitive cancers (prostate, testicular) — potential stimulation of androgen-dependent pathways
- xPregnancy and breastfeeding (female partners) — not applicable for direct use but consider reproductive implications
- xSevere hepatic or renal impairment — peptide metabolism may be altered
Decision Guide
Which is
right for you?
Choose Prostamax if...
- Age-related benign prostatic hyperplasia (BPH) requiring tissue-level normalization
- Prostate geroprotection — preserving prostatic epithelial function during aging
- Chronic prostatitis support through anti-inflammatory tissue-level mechanisms
- Comprehensive Khavinson bioregulator protocols targeting male genitourinary health
Choose Testagen if...
- Age-related testosterone decline (andropause) requiring physiological restoration rather than replacement
- HPG axis normalization in aging males with suboptimal hormonal signaling
- Comprehensive Khavinson bioregulator protocols targeting male reproductive health
- Testicular geroprotection — preserving Leydig and Sertoli cell function during aging